Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Upstream and downstream of mTOR.

Hay N, Sonenberg N.

Genes Dev. 2004 Aug 15;18(16):1926-45. Review.

2.

Rheb activation of mTOR and S6K1 signaling.

Hanrahan J, Blenis J.

Methods Enzymol. 2006;407:542-55.

PMID:
16757352
3.

When translation meets transformation: the mTOR story.

Averous J, Proud CG.

Oncogene. 2006 Oct 16;25(48):6423-35. Review.

PMID:
17041627
4.

The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.

Yang X, Yang C, Farberman A, Rideout TC, de Lange CF, France J, Fan MZ.

J Anim Sci. 2008 Apr;86(14 Suppl):E36-50. Epub 2007 Nov 12. Review.

5.
6.

Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.

Avruch J, Hara K, Lin Y, Liu M, Long X, Ortiz-Vega S, Yonezawa K.

Oncogene. 2006 Oct 16;25(48):6361-72. Review.

PMID:
17041622
7.

Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function.

Jastrzebski K, Hannan KM, Tchoubrieva EB, Hannan RD, Pearson RB.

Growth Factors. 2007 Aug;25(4):209-26. Review.

PMID:
18092230
8.

The mammalian target of rapamycin pathway and its role in molecular nutrition regulation.

Lian J, Yan XH, Peng J, Jiang SW.

Mol Nutr Food Res. 2008 Apr;52(4):393-9. doi: 10.1002/mnfr.200700005. Review.

PMID:
18306429
9.

Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.

Ruvinsky I, Meyuhas O.

Trends Biochem Sci. 2006 Jun;31(6):342-8. Epub 2006 May 6. Review.

PMID:
16679021
11.

Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets.

Kwon G, Marshall CA, Pappan KL, Remedi MS, McDaniel ML.

Diabetes. 2004 Dec;53 Suppl 3:S225-32. Review.

12.

Therapeutic potential of target of rapamycin inhibitors.

Easton JB, Houghton PJ.

Expert Opin Ther Targets. 2004 Dec;8(6):551-64. Review.

PMID:
15584862
13.

Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region.

Takahara T, Hara K, Yonezawa K, Sorimachi H, Maeda T.

J Biol Chem. 2006 Sep 29;281(39):28605-14. Epub 2006 Jul 26.

14.

Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.

Amornphimoltham P, Patel V, Sodhi A, Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA, Gutkind JS.

Cancer Res. 2005 Nov 1;65(21):9953-61.

15.

mTOR, translation initiation and cancer.

Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N.

Oncogene. 2006 Oct 16;25(48):6416-22. Review.

PMID:
17041626
16.

Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site.

Ali SM, Sabatini DM.

J Biol Chem. 2005 May 20;280(20):19445-8. Epub 2005 Apr 4.

17.

Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.

Williamson DL, Bolster DR, Kimball SR, Jefferson LS.

Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E80-9.

18.

IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.

Bibollet-Bahena O, Almazan G.

J Neurochem. 2009 Jun;109(5):1440-51. doi: 10.1111/j.1471-4159.2009.06071.x. Epub 2009 Mar 28.

19.
20.

Expanding mTOR signaling.

Yang Q, Guan KL.

Cell Res. 2007 Aug;17(8):666-81. Review.

Supplemental Content

Support Center